April 23, 2009 at 10:48 AM EDT
Roche's shares resume retreat; Novartis gains
Roche Holdings leads drug stocks lower as the Swiss drug maker loses ground for a second straight session on disappointing news about Avastin, the company’s top-selling drug. Well-received financial results reported by Novartis give its shares a lift.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here